State of Wisconsin Investment Board’s Biotech Acquisition Company Warrant BIOTW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-37,500
Closed -$2.4K 2656
2022
Q4
$2.4K Hold
37,500
﹤0.01% 2484
2022
Q3
$2K Hold
37,500
﹤0.01% 2671
2022
Q2
$3K Hold
37,500
﹤0.01% 2779
2022
Q1
$9K Hold
37,500
﹤0.01% 2263
2021
Q4
$25K Buy
+37,500
New +$26K ﹤0.01% 2139

State of Wisconsin Investment Board's BIOTW Position: Q1 2023 in Review

State of Wisconsin Investment Board sold out of Biotech Acquisition Company Warrant (BIOTW) in Q1 2023, closing a stake of 37,500 shares — an estimated $2.4K sold.

State of Wisconsin Investment Board first reported a position in BIOTW in Q4 2021 and held it in 5 quarters. The position peaked at $25K in Q4 2021. 0 funds tracked by Wall St. Rank hold BIOTW as of Q1 2023.

  • State of Wisconsin Investment Board reported no remaining Biotech Acquisition Company Warrant position as of Q1 2023 after selling out during the quarter.
  • State of Wisconsin Investment Board sold 37,500 Biotech Acquisition Company Warrant shares in Q1 2023, an estimated $2.4K.
  • State of Wisconsin Investment Board first reported a position in Biotech Acquisition Company Warrant in Q4 2021 and held it in 5 quarters.
  • State of Wisconsin Investment Board's Biotech Acquisition Company Warrant position peaked at $25K in Q4 2021.
  • 0 funds tracked by Wall St. Rank held Biotech Acquisition Company Warrant as of Q1 2023.

Based on State of Wisconsin Investment Board's 13F filing for Q1 2023, filed 15 May 2023.